The first TNBC Drug Development Digital Summit begins tomorrow. Our Founder and CEO, Dr. Sandra Dunn, will be speaking on Thursday, April 29 at 8:30 am PST.

Don't miss her and other industry leaders from MD Anderson Cancer Center, Stanford University, Triple Negative Breast Cancer Foundation, Moffit Cancer Center, and Tigerlily Foundation speak about the discovery and development of TNBC treatments to reach patients in need.